Specificity of mannan antigen and anti-mannan antibody screening in patients with haematological malignancies at risk for fungal infection

Influence of mould-active antifungal treatment on the performance of the Aspergillus-specific bronchoalveolar lavage fluid lateral-flow device test

(2015) Susanne Eigl et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Diagnostic accuracy of theAspergillus-specific bronchoalveolar lavage lateral-flow assay in haematological malignancy patients

(2015) Juergen Prattes et al.   MYCOSES

Primary prophylaxis of invasive fungal infections in patients with haematologic malignancies. 2014 update of the recommendations of the Infectious Diseases Working Party of the German Society for Haematology and Oncology

(2014) Daniela Tacke et al.   ANNALS OF HEMATOLOGY

Primary antifungal prophylaxis with micafungin in patients with haematological malignancies: real-life data from a retrospective single-centre observational study

(2014) David Nachbaur et al.   EUROPEAN JOURNAL OF HAEMATOLOGY

Non-cultural methods for the diagnosis of invasive fungal disease

(2014) Małgorzata Mikulska et al.   Expert Review of Anti-Infective Therapy

Impact of structured personal on-site patient education on low posaconazole plasma concentrations in patients with haematological malignancies

(2014) Martin Hoenigl et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Characteristic and clinical relevance of Candida mannan test in the diagnosis of probable invasive candidiasis

(2014) B. F. F. Chumpitazi et al.   MEDICAL MYCOLOGY

Our 2014 approach to candidaemia

(2014) Philipp Koehler et al.   MYCOSES

Serum 1,3-beta-d-glucan for antifungal treatment stratification at the intensive care unit and the influence of surgery

(2014) Jürgen Prattes et al.   MYCOSES

Potential Factors for Inadequate Voriconazole Plasma Concentrations in Intensive Care Unit Patients and Patients with Hematological Malignancies

(2013) Martin Hoenigl et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Comparison of (1->3)- -D-Glucan, Mannan/Anti-Mannan Antibodies, and Cand-Tec Candida Antigen as Serum Biomarkers for Candidemia

(2013) J. Held et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Sensitivity of galactomannan enzyme immunoassay for diagnosing breakthrough invasive aspergillosis under antifungal prophylaxis and empirical therapy

(2013) Martin Hoenigl et al.   MYCOSES

Performance of Candida Real-time Polymerase Chain Reaction,  -D-Glucan Assay, and Blood Cultures in the Diagnosis of Invasive Candidiasis

(2012) M. H. Nguyen et al.   CLINICAL INFECTIOUS DISEASES

European Organization for the Research and Treatment of Cancer/Mycoses Study Group (EORTC/MSG) host factors and invasive fungal infections in patients with haematological malignancies

(2012) M. Hoenigl et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Diagnosis and therapy of Candida infections: joint recommendations of the German Speaking Mycological Society and the Paul-Ehrlich-Society for Chemotherapy

(2011) Markus Ruhnke et al.   MYCOSES

Circulating Candida-specific anti-mannan antibodies precede invasive candidiasis in patients undergoing myelo-ablative chemotherapy

(2009) F. M. Verduyn Lunel et al.   CLINICAL MICROBIOLOGY AND INFECTION

Revised Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group

(2008) Ben De Pauw et al.   CLINICAL INFECTIOUS DISEASES